Reilly et al. synthesized radiobioconjugates by the modification of gold nanoparticles (30 nm) with polyethylene glycol chains linked to trastuzumab to target HER2-positive breast cancer (BC) cells and DTPA chelator to complex 111In [68,69]. This evidence concerns the gene ERBB2 and breast cancer.